Expiration date: 07/2026

Indications for use:

Parkinsonism syndrome (as part of combination therapy), including the initial stages of Parkinson's disease (monotherapy). Extrapyramidal disorders (tremor, muscle rigidity, torsion dystonia and local forms of dystonia, including paroxysmal dyskinesia, hyperkinesis of chorea, various forms of tics, myoclonia and hyperkinesis, dystonia of the muscles of the extremities, trunk, neck, face, akinesia, akathisia) caused by drugs (in particular neuroleptics).

Side effects

Basically, side effects develop as a result of the anticholinergic action of the drug. Dry mouth, mydriasis, paresis of accommodation, which are dose-dependent side effects, are most often observed. Rarely constipation, dyspepsia, fatigue, weakness, dizziness, drowsiness, anxiety, confusion, memory impairment, hallucinations, euphoria, disorientation in time and space, motor excitement, catalepsy, urinary retention, tachycardia, decreased blood pressure, drug dependence, allergic reactions (skin rash).

The tablets are white, round, biconvex, with a risk on one side.

Biperiden hydrochloride

2 mg

Excipients: magnesium stearate 2 mg, lactose monohydrate 65 mg, microcrystalline cellulose 131 mg.

10 pcs. - cell contour packages (5) - cardboard packs.